Maftivimab

Maftivimab (REGN3470-3471-3479), the inhibitor of Filovirus, is an Food and agent Administration (FDA) -approved agent. Maftivimab, also named as Atoltivimab, Odesivimab (Inmazeb), can be used for research of Zaire ebolavirus infection[1].

Product Specifications

CAS Number

[2135632-36-7]

Product Name Alternative

REGN3470-3471-3479

UNSPSC

12352203

Target

Filovirus

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/maftivimab.html

Purity

96.89

Solubility

10 mM in DMSO

Smiles

[Maftivimab]

Molecular Weight

(143.94 kDa)

References & Citations

[1]Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc) . 2021 Aug;57 (8) :483-490.